Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
Enrolling by invitation · NCT05305612 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Enrolling by invitation | Phase 4 | 2026-09-17 | NCT05305612 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical Research Agency, Poland | 33 |
| National Institute of Cardiology, Warsaw, Poland | 14 |
| Soft Communication, Poland | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Górnośląskie Centrum Medyczne im. Leszka Gieca Śląskiego Uniwersytetu Medycznego | Katowice | Poland | 1 |
| Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie | Lublin | Poland | 2 |
| Uniwersytecki Szpital Kliniczny W Poznaniu | Poznan | Poland | 5 |
| Uniwersyteckie Centrum Kliniczne Gdański Uniwersytet Medyczny | Gdansk | Poland | 1 |
| Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | Warsaw | Poland | 4 |